2025 CDISC + TMF US Interchange Program

Program is preliminary and subject to change.
TMF Topics Coming Soon!
Session 1: Opening Plenary & Keynote Presentation
Symphony Ballroom
Morning Break
Symphony Foyer
Session 2: Track A, B, & C - 360i Vision & Roadmap
Symphony Ballroom
Lunch Break & Poster Session
Symphony Foyer & Starstruck
Session 3: Track A - 360i Progress & Next Steps
Symphony I
Session 3: Track B - Foundational Standards (ADaM, CDASH)
Symphony II
Session 3: Track C - Innovation Showcase: How Industry Is Innovating through CDISC
Symphony III
The 2025 CDISC US Interchange will include an Innovation Showcase during the Main Conference. This 90-minute session includes six, 15-minute slots for vendors to present how their solutions leverage CDISC standards to drive industry transformation.
This unique opportunity is available to all, with exclusive discounts for our valued Sponsors and Exhibitors. Spots are limited; sign up today!
Afternoon Break
Symphony Foyer
Session 4: Track A - Digital Study Design
Symphony I
Session 4: Track B - Special Topics
Symphony II
Session 4: Track C - Regulatory Submission
Symphony III
Session 5: Track A - 360i, Part II
Symphony I
Session 5: Track B - What's New in SDTMIG 4.0 and SDTM 3.0
Symphony II
Session 5: Track C - Innovation in Clinical Trials
Symphony III
Morning Break
Symphony Foyer
Session 6: Track A - 360i, Part III (DDF / Protocol)
Symphony I
Session 6: Track B - New Data Sources (RWD)
Symphony II
Session 6: Track C - Innovation in Clinical Trials
Symphony III
Lunch
Symphony Foyer
Session 7: Tracks A, B, & C - Evolving Data Standards Role in Digital Age
Symphony Ballroom
The digitalization of healthcare and advancing science and technologies are driving evolution. Biopharma companies, regulatory agencies, academic institutes, technology vendors and standards development organizations must adapt to this new environment. Hence, a significant challenge for the data standards community is keeping pace with the sheer breadth and depth of disease areas for which therapies are being developed across the biopharmaceutical industry, and the myriad of data types (including biomarker, genomic, imaging real world data, and various digital health technologies) being collected and used for analysis and reporting for decision making.
Leaders in the data standards community will share examples for current Data Standards Governance and evolving Data Standards roles, challenges being faced and aspects of where we are going, and how the Data Standards roles are evolving to thrive in the Digital Age with rapidly advancing science and healthcare needs.
Speakers and Panelists:
- Miho Hashio, GSK
- Jonathan Chainey, Roche
- Other speakers invited